Nasdaq:US$15.88 (-0.33) | HKEX:HK$25.14 (-0.10) | AIM:£2.31 (-0.1)
搜索结果
上一篇文章   |   下一篇文章
公告及新闻稿, 肿瘤学 / 免疫学 | 2007-07-02

Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis